Jesper Hjortnaes1,2, Kayle Shapero3, Claudia Goettsch4, Joshua D Hutcheson4, Joshua Keegan1, Jolanda Kluin2, John E Mayer5, Joyce Bischoff3, Elena Aikawa1,4. 1. Center of Excellence in Vascular Biology, Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston. 2. Department of Cardiothoracic Surgery, University Medical Center Utrecht, Utrecht, The Netherlands. 3. Vascular Biology Program and Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston. 4. Center for Interdisciplinary Cardiovascular Sciences, Brigham and Women's Hospital, Harvard Medical School, Boston. 5. Department of Thoracic Surgery, Boston Children's Hospital, Harvard Medical School, Boston.
Abstract
BACKGROUND: Calcific aortic valve disease (CAVD) is the most common heart valve disease in the Western world. We previously proposed that valvular endothelial cells (VECs) replenish injured adult valve leaflets via endothelial-to-mesenchymal transformation (EndMT); however, whether EndMT contributes to valvular calcification is unknown. We hypothesized that aortic VECs undergo osteogenic differentiation via an EndMT process that can be inhibited by valvular interstitial cells (VICs). APPROACH AND RESULTS: VEC clones underwent TGF-β1-mediated EndMT, shown by significantly increased mRNA expression of the EndMT markers α-SMA (5.3 ± 1.2), MMP-2 (13.5 ± 0.6) and Slug (12 ± 2.1) (p < 0.05), (compared to unstimulated controls). To study the effects of VIC on VEC EndMT, clonal populations of VICs were derived from the same valve leaflets, placed in co-culture with VECs, and grown in control/TGF-β1 supplemented media. In the presence of VICs, EndMT was inhibited, shown by decreased mRNA expression of α-SMA (0.1 ± 0.5), MMP-2 (0.1 ± 0.1), and Slug (0.2 ± 0.2) (p < 0.05). When cultured in osteogenic media, VECs demonstrated osteogenic changes confirmed by increase in mRNA expression of osteocalcin (8.6 ± 1.3), osteopontin (3.7 ± 0.3), and Runx2 (5.5 ± 1.5). The VIC presence inhibited VEC osteogenesis, demonstrated by decreased expression of osteocalcin (0.4 ± 0.1) and osteopontin (0.2 ± 0.1) (p < 0.05). Time course analysis suggested that EndMT precedes osteogenesis, shown by an initial increase of α-SMA and MMP-2 (day 7), followed by an increase of osteopontin and osteocalcin (day 14). CONCLUSIONS: The data indicate that EndMT may precede VEC osteogenesis. This study shows that VICs inhibit VEC EndMT and osteogenesis, indicating the importance of VEC-VIC interactions in valve homeostasis.
BACKGROUND:Calcific aortic valve disease (CAVD) is the most common heart valve disease in the Western world. We previously proposed that valvular endothelial cells (VECs) replenish injured adult valve leaflets via endothelial-to-mesenchymal transformation (EndMT); however, whether EndMT contributes to valvular calcification is unknown. We hypothesized that aortic VECs undergo osteogenic differentiation via an EndMT process that can be inhibited by valvular interstitial cells (VICs). APPROACH AND RESULTS: VEC clones underwent TGF-β1-mediated EndMT, shown by significantly increased mRNA expression of the EndMT markers α-SMA (5.3 ± 1.2), MMP-2 (13.5 ± 0.6) and Slug (12 ± 2.1) (p < 0.05), (compared to unstimulated controls). To study the effects of VIC on VEC EndMT, clonal populations of VICs were derived from the same valve leaflets, placed in co-culture with VECs, and grown in control/TGF-β1 supplemented media. In the presence of VICs, EndMT was inhibited, shown by decreased mRNA expression of α-SMA (0.1 ± 0.5), MMP-2 (0.1 ± 0.1), and Slug (0.2 ± 0.2) (p < 0.05). When cultured in osteogenic media, VECs demonstrated osteogenic changes confirmed by increase in mRNA expression of osteocalcin (8.6 ± 1.3), osteopontin (3.7 ± 0.3), and Runx2 (5.5 ± 1.5). The VIC presence inhibited VEC osteogenesis, demonstrated by decreased expression of osteocalcin (0.4 ± 0.1) and osteopontin (0.2 ± 0.1) (p < 0.05). Time course analysis suggested that EndMT precedes osteogenesis, shown by an initial increase of α-SMA and MMP-2 (day 7), followed by an increase of osteopontin and osteocalcin (day 14). CONCLUSIONS: The data indicate that EndMT may precede VEC osteogenesis. This study shows that VICs inhibit VEC EndMT and osteogenesis, indicating the importance of VEC-VIC interactions in valve homeostasis.
Authors: Sailaja Paruchuri; Jeong-Hee Yang; Elena Aikawa; Juan M Melero-Martin; Zia A Khan; Stavros Loukogeorgakis; Frederick J Schoen; Joyce Bischoff Journal: Circ Res Date: 2006-09-14 Impact factor: 17.367
Authors: Elena Aikawa; Matthias Nahrendorf; David Sosnovik; Vincent M Lok; Farouc A Jaffer; Masanori Aikawa; Ralph Weissleder Journal: Circulation Date: 2007-01-15 Impact factor: 29.690
Authors: Robert B Hinton; Joy Lincoln; Gail H Deutsch; Hanna Osinska; Peter B Manning; D Woodrow Benson; Katherine E Yutzey Journal: Circ Res Date: 2006-04-27 Impact factor: 17.367
Authors: Jacob P Dal-Bianco; Elena Aikawa; Joyce Bischoff; J Luis Guerrero; Mark D Handschumacher; Suzanne Sullivan; Benjamin Johnson; James S Titus; Yoshiko Iwamoto; Jill Wylie-Sears; Robert A Levine; Alain Carpentier Journal: Circulation Date: 2009-07-13 Impact factor: 29.690
Authors: Andrew C Dudley; Zia A Khan; Shou-Ching Shih; Soo-Young Kang; Bernadette M M Zwaans; Joyce Bischoff; Michael Klagsbrun Journal: Cancer Cell Date: 2008-09-09 Impact factor: 31.743
Authors: Jason C Kovacic; Stefanie Dimmeler; Richard P Harvey; Toren Finkel; Elena Aikawa; Guido Krenning; Andrew H Baker Journal: J Am Coll Cardiol Date: 2019-01-22 Impact factor: 24.094
Authors: Casper F T van der Ven; Pin-Jou Wu; Mark W Tibbitt; Alain van Mil; Joost P G Sluijter; Robert Langer; Elena Aikawa Journal: Clin Sci (Lond) Date: 2017-02-01 Impact factor: 6.124